BIOMAT Database Logo BIOMAT Database Logo

Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series. 1996

A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Laboratoire de Pharmacognosie de l'Université René Descartes, URA au CNRS no. 1310, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France.

Seven 1,2-dihydroxy-1,2-dihydroacronycine and 1,2-dihydroxy-1,2-dihydro-6-demethoxyacronycine esters and diesters were synthesized via osmic oxidation of acronycine or 6-demethoxyacronycine followed by acylation. The 6-demethoxyacronycine derivatives were found to be inactive, whereas in contrast, all of the acronycine derivatives were more potent than acronycine itself when tested against L1210 cells in vitro. Four selected acronycine derivatives (17,19, 21, and 22) were evaluated in vivo against murine P388 leukemia and colon 38 adenocarcinoma implanted in mice. All compounds were markedly active against P388 at doses 4-16-fold lower than acronycine itself. Against the colon 38 adenocarcinoma, the three compounds 17, 21, and 22 were highly efficient. 1,2-Diacetoxy-1,2-dihydroacronycine (17) was the most active, all the treated mice being tumor-free on day 23.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000175 Acronine A pyrano-acridone alkaloid found in RUTACEAE plants. Acronycine,Acronycin
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
February 1998, Journal of natural products,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
March 2009, Bioorganic & medicinal chemistry,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
March 2004, Chemical & pharmaceutical bulletin,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis and cytotoxic activity of 1-alkoxy- and 1-amino-2-hydroxy-1,2-dihydroacronycine derivatives.
May 1999, Chemical & pharmaceutical bulletin,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Chiral dihydroxylation of acronycine: absolute configuration of natural cis-1,2-dihydroxy-1,2-dihydroacronycine and cytotoxicity of (1R,2R)- and (1S,2S)-1,2-diacetoxy-1,2-dihydroacronycine.
March 1999, Journal of natural products,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Chemistry of Acronycine; Part 1. Synthesis of 1-Hydroxy-1,2-dihydroacronycine and 2-Hydroxy-1,2-dihydroacronycine.
February 1988, Planta medica,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis and anti-proliferative activity of 2-hydroxy-1,2-dihydroacronycine glycosides.
June 1996, Pharmaceutical research,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Alkyl and carboxylalkyl esters of 4'-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity.
February 2004, European journal of medicinal chemistry,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Synthesis and antitumor activity of aromatic camptothecin esters.
April 2008, International journal of molecular medicine,
A Elomri, and S Mitaku, and S Michel, and A L Skaltsounis, and F Tillequin, and M Koch, and A Pierré, and N Guilbaud, and S Léonce, and L Kraus-Berthier, and Y Rolland, and G Atassi
Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine series.
August 2005, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!